UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.125-131

2011

Volltextzugriff (PDF)

Validation of the INNO-LiPA HBV DR Assay (Version 2) in Monitoring Hepatitis B Virus-Infected Patients Receiving Nucleoside Analog Treatment

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1283-1289

2010

Volltextzugriff (PDF)

European Multicenter Evaluation of High-Density DNA Probe Arrays for Detection of Hepatitis B Virus Resistance Mutations and Identification of Genotypes

Journal of Clinical Microbiology, 2006-08, Vol.44 (8), p.2792-2800

2006

Volltextzugriff (PDF)

In Vitro Characterization of the Anti-Hepatitis B Virus Activity and Cross-Resistance Profile of 2′,3′-Dideoxy-3′-Fluoroguanosine

Antimicrobial Agents and Chemotherapy, 2006-03, Vol.50 (3), p.955-961

2006

Volltextzugriff (PDF)

458 N-GLYCOSYLATION MUTATIONS WITHIN HBSAG MAJOR HYDROPHILIC REGION CONTRIBUTE MOSTLY TO HEPATITIS B VIRUS IMMUNE ESCAPE MUTANT THROUGH ENHANCING VIRAL FITNESS

Journal of hepatology, 2012-04, Vol.56, p.S181-S181

2012

Volltextzugriff (PDF)

Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B

Journal of hepatology, 2000-02, Vol.32 (2), p.307-316

2000

Volltextzugriff (PDF)

Effect of a Combination of Clevudine and Emtricitabine with Adenovirus-Mediated Delivery of Gamma Interferon in the Woodchuck Model of Hepatitis B Virus Infection

Antimicrobial Agents and Chemotherapy, 2004-07, Vol.48 (7), p.2683-2692

2004

Volltextzugriff (PDF)

934 EVOLUTION OF VIRAL LOAD AND GENOME SEQUENCE IN A CLINICAL TRIAL OF TENOFOVIR/EMTRICITABINE COMBINATION VERSUS TENOFOVIR MONOTHERAPY FOR PATIENTS WITH PREVIOUS ADEFOVIR DIPIVOXIL FAILURE

Journal of hepatology, 2009, Vol.50, p.S340-S340

2009

Volltextzugriff (PDF)

[794] WHAT IS THE ROLE OF HBV RTA181V/T MUTANTS IN HEPATITIS B TREATMENT FAILURE?

Journal of hepatology, 2007, Vol.46, p.S299-S299

2007

Volltextzugriff (PDF)

Antiviral Activity of β-l-2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus

Antimicrobial Agents and Chemotherapy, 2001-04, Vol.45 (4), p.1065-1077

2001

Volltextzugriff (PDF)

681 INFECTIVITY PLAYS A MAJOR ROLE IN THE SELECTION OF HBV VARIANTS DURING ANTI-HBV THERAPY

Journal of hepatology, 2008, Vol.48, p.S253-S253

2008

Volltextzugriff (PDF)

Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir

Hepatology (Baltimore, Md.), 2005-06, Vol.41 (6), p.1391-1398

2005

Volltextzugriff (PDF)

680 HBV PHENOSCRIPT®: AN IN VITRO HIGH THROUGHPUT ASSAY FOR TESTING DRUG SUSCEPTIBILITY OF HBV STRAINS ISOLATED FROM PATIENTS

Journal of hepatology, 2008, Vol.48, p.S253-S253

2008

Volltextzugriff (PDF)

Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies

Journal of gastroenterology and hepatology, 2002-12, Vol.17 (s4), p.S460-S463

2002

Volltextzugriff (PDF)

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

Journal of hepatology, 2000-09, Vol.33 (3), p.430-439

2000

Volltextzugriff (PDF)

Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses

Hepatology (Baltimore, Md.), 2002-09, Vol.36 (3), p.710-722

2002

Volltextzugriff (PDF)

Traitement des hépatites C

Pathologie biologie (Paris), 1995, Vol.43 (8), p.716-724

1995

Volltextzugriff (PDF)

Early Detection of Viral Resistance by Determination of Hepatitis B Virus Polymerase Mutations in Patients Treated by Lamivudine for Chronic Hepatitis B

Hepatology (Baltimore, Md.), 2000-11, Vol.32 (5), p.1078-1088

2000

Volltextzugriff (PDF)

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus

Hepatology (Baltimore, Md.), 2004-10, Vol.40 (4), p.855-864

2004

Volltextzugriff (PDF)

Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants

Antiviral therapy, 2008-01, Vol.13 (3), p.381-388

2008

Volltextzugriff (PDF)

Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing

Journal of clinical virology, 2005-12, Vol.34, p.S34-S43

2005

Volltextzugriff (PDF)

Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance

Hepatology (Baltimore, Md.), 1999-01, Vol.29 (1), p.230-237

1999

Volltextzugriff (PDF)

Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model

Antimicrobial Agents and Chemotherapy, 2000-01, Vol.44 (1), p.111-122

2000

Volltextzugriff (PDF)

Diagnostic markers of viral hepatitis B and C

Gut, 1993, Vol.34 (2), p.S20-S25

1993

Volltextzugriff (PDF)

Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger

The American journal of tropical medicine and hygiene, 1995-04, Vol.52 (4), p.293-296

1995

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(85)
Tagungsberichte
(1)

Sprache

Englisch
(72)
Französisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(47)
Humans
(44)
Biological And Medical Sciences
(43)
Medical Sciences
(34)
Infectious Diseases
(27)
Viral Diseases
(24)
Hepatitis B Virus
(23)
Human Viral Diseases
(22)
Viral Hepatitis
(22)
Microbiology
(21)
Animals
(18)
Hepatitis B Virus - Genetics
(17)
Virology
(16)
Male
(15)
Gastroenterology & Hepatology
(14)
Fundamental And Applied Biological Sciences. Psychology
(13)
Adult
(12)
Female
(12)
Chronic Disease
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT

Validation of the INNO-LiPA HBV DR Assay (Version 2) in Monitoring Hepatitis B Virus-Infected Patients Receiving Nucleoside Analog Treatment

European Multicenter Evaluation of High-Density DNA Probe Arrays for Detection of Hepatitis B Virus Resistance Mutations and Identification of Genotypes

In Vitro Characterization of the Anti-Hepatitis B Virus Activity and Cross-Resistance Profile of 2′,3′-Dideoxy-3′-Fluoroguanosine

458 N-GLYCOSYLATION MUTATIONS WITHIN HBSAG MAJOR HYDROPHILIC REGION CONTRIBUTE MOSTLY TO HEPATITIS B VIRUS IMMUNE ESCAPE MUTANT THROUGH ENHANCING VIRAL FITNESS

Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B

Effect of a Combination of Clevudine and Emtricitabine with Adenovirus-Mediated Delivery of Gamma Interferon in the Woodchuck Model of Hepatitis B Virus Infection

934 EVOLUTION OF VIRAL LOAD AND GENOME SEQUENCE IN A CLINICAL TRIAL OF TENOFOVIR/EMTRICITABINE COMBINATION VERSUS TENOFOVIR MONOTHERAPY FOR PATIENTS WITH PREVIOUS ADEFOVIR DIPIVOXIL FAILURE

[794] WHAT IS THE ROLE OF HBV RTA181V/T MUTANTS IN HEPATITIS B TREATMENT FAILURE?

Antiviral Activity of β-l-2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus

681 INFECTIVITY PLAYS A MAJOR ROLE IN THE SELECTION OF HBV VARIANTS DURING ANTI-HBV THERAPY

Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir

680 HBV PHENOSCRIPT®: AN IN VITRO HIGH THROUGHPUT ASSAY FOR TESTING DRUG SUSCEPTIBILITY OF HBV STRAINS ISOLATED FROM PATIENTS

Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses

Traitement des hépatites C

Early Detection of Viral Resistance by Determination of Hepatitis B Virus Polymerase Mutations in Patients Treated by Lamivudine for Chronic Hepatitis B

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus

Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants

Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing

Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance

Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model

Diagnostic markers of viral hepatitis B and C

Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger

Suchergebnisse filtern